Skip to search formSkip to main content

NSC 109268

Known as: NSC-109268, NSC109268 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
The success of cisplatin (CP) based therapy is often hindered by acquisition of CP resistance. We isolated NSC109268 as a… Expand
Is this relevant?
2010
2010
PurposeNSC109268 has been described previously as inhibitor of proteasomal degradation and of phosphatase 2Cα. In a yeast screen… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2010
2010
BACKGROUND Ovarian cancer is the leading cause of death among gynecological cancers. Cisplatin is one of the most effective… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2010
2010
Background: Ovarian cancer is the leading cause of death among gynecological cancers. Cisplatin is one of the most effective… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?